LM
Therapeutic Areas
PharmaMar Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Zepzelca (lurbinectedin) | Relapsed Small Cell Lung Cancer | Phase 3 |
| PM14 | Advanced Solid Tumors | Phase 1/2 |
| Aplidin (plitidepsin) | Relapsed/Refractory Multiple Myeloma | Approved (Conditional - AU) |
| Ecubectedin (PM54) | Advanced Solid Tumors | Phase 1 |
| Yondelis (trabectedin) | Soft Tissue Sarcoma | Approved |